Ignite Creation Date:
2024-05-06 @ 10:54 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03386162
Status:
TERMINATED
Last Update Posted:
2022-11-28
First Post:
2017-12-21
Brief Title:
SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in PIK3CA Mutated Advanced Breast Cancer
Sponsor:
UNICANCER
Organization:
UNICANCER
Organization Data
Organization:
UNICANCER
Class:
OTHER
Study ID:
UC-01051701
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UNICANCER
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None